Rate My Professor Clark Anderson

Anderson's research has centered on the mechanisms by which IgG antibodies mediate effects through Fc gamma receptors, IgG catabolism and protection by the neonatal Fc receptor (FcRn), albumin homeostasis, and clearance of blood-borne particles, viruses, and LPS by liver sinusoidal endothelial cells. He identified key Fc gamma receptors, developed monoclonal antibodies such as mAb 32 and IV.3 (U.S. Patent 4,954,617, 1990), confirmed FcRn's role in prolonging IgG and albumin lifespan (binding stoichiometries 2:1:1), and demonstrated liver sinusoidal endothelial cells eliminate up to 100 million HIV-like particles per minute in mice via second-order kinetics and scavenger receptor SR-BI with HDL. With over 200 publications and thousands of citations, notable works include 'Human leukocyte IgG Fc receptors' (Immunol Today, 1986), 'The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor' (PNAS, 1996), 'The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan' (J Exp Med, 2003), 'Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene' (PNAS, 2006), 'Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal Endothelium' (PLoS Pathog, 2011), and 'Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein' (J Immunol, 2016). His findings have shaped immunology, influenced biopharmaceutical strategies for protein half-life extension, and corrected misconceptions about Kupffer cell dominance in clearance.